Uncontrolled atrial fibrillation (afib) means the heart’s upper chambers are beating chaotically and the resulting heart rate stays too fast, typically above 100 to 110 beats per minute at rest, despite the condition being known about or even treated. In people with uncontrolled afib, heart rates can range from 100 to 175 beats per minute. The distinction between “controlled” and “uncontrolled” comes down to whether that ventricular rate, the speed the lower chambers actually pump at, has been brought into a safe range.
How Controlled and Uncontrolled Afib Differ
In all forms of afib, the upper chambers of the heart quiver erratically instead of contracting in a coordinated way. That part doesn’t change whether afib is “controlled” or not. What changes is how fast the lower chambers respond. When electrical signals from the chaotic upper chambers pass through to the lower chambers unchecked, the heart races. That rapid pumping is what doctors call a rapid ventricular response, and it’s the hallmark of uncontrolled afib.
The most widely referenced target for rate control comes from major clinical trials. In the AFFIRM trial, the goal was a resting heart rate of 80 beats per minute or below, and no higher than 110 during moderate activity like a six-minute walk. A later study called RACE II tested a more lenient target of simply keeping the resting rate below 110 and found similar outcomes. So in practical terms, if your resting heart rate consistently sits above 110 while in afib, most cardiologists would consider that uncontrolled. Between 80 and 110, there’s some flexibility depending on your symptoms and overall heart health.
Symptoms of Uncontrolled Afib
Some people with well-controlled afib feel almost nothing. Uncontrolled afib is harder to ignore. The most common symptoms include a fast, fluttering, or pounding heartbeat (palpitations), shortness of breath, fatigue, dizziness or lightheadedness, chest pain, weakness, and a noticeable drop in your ability to exercise or do physical tasks you could handle before. These symptoms tend to worsen with activity and may be constant or come in episodes lasting minutes to days.
Afib itself can follow different patterns. It may be occasional (paroxysmal), coming and going in episodes that last minutes to hours, sometimes up to a week. It can also be persistent or permanent. Any of these patterns can be uncontrolled if the heart rate stays elevated during episodes.
What Happens to the Heart Over Time
A chronically fast heart rate doesn’t just cause uncomfortable symptoms. It can physically damage the heart muscle, a condition called tachycardia-induced cardiomyopathy. When the heart races for weeks or months without adequate rest periods, the muscle cells begin to stretch and weaken. The heart chambers dilate, the walls thin, and the organ gradually loses its ability to pump blood efficiently. At a cellular level, the heart’s energy stores become depleted, mitochondria (the energy-producing structures inside cells) sustain damage, and oxidative stress accelerates the death of heart muscle cells.
Blood flow within the heart muscle itself also suffers. The coronary capillaries, the tiny vessels that feed the heart, remodel in ways that reduce oxygen delivery. Parts of the heart can essentially go into a state of hibernation due to this low-grade ischemia. The body tries to compensate by ramping up stress hormones and constricting blood vessels, which raises the pressure the weakened heart has to pump against, creating a vicious cycle that can progress to heart failure.
The encouraging part is that much of this damage is reversible. When the heart rate is brought back under control, the heart can recover significant function. This reversibility is one of the main reasons doctors treat uncontrolled afib aggressively.
Stroke Risk
Afib, whether controlled or uncontrolled, raises stroke risk because blood can pool and clot in the quivering upper chambers. This is why most people with afib take blood thinners regardless of whether their rate is well managed. In the major AFFIRM trial, the rate of stroke was approximately 1 percent per year in both the rate-controlled and rhythm-controlled groups, reinforcing that anticoagulation matters more than the rate control strategy itself when it comes to preventing strokes.
The warning signs of a stroke in someone with afib include face drooping, confusion, slurred speech, dizziness or balance problems, numbness or weakness on one side of the body, and sudden severe headache or vision changes. These require emergency care immediately.
How Doctors Measure Control
A single heart rate reading in a clinic doesn’t always tell the full story, especially with afib that comes and goes. Doctors often use continuous heart monitors worn for 24 hours to two weeks to get a clearer picture. These devices track your heart rate around the clock and can measure what’s sometimes called “afib burden,” the proportion of monitored time you actually spend in afib and how fast your heart goes during those episodes. This data helps determine whether your afib is truly controlled during daily life, not just during a brief office visit.
Rate Control vs. Rhythm Control
There are two broad strategies for managing afib. Rate control accepts that the heart will stay in afib but uses medications to keep the ventricular rate in a safe range. Common drug classes for this include beta-blockers, certain calcium channel blockers, and digoxin. Rhythm control tries to restore and maintain a normal heart rhythm using antiarrhythmic medications, electrical cardioversion (a brief shock to reset the rhythm), or catheter ablation procedures.
For years, a landmark trial published in the New England Journal of Medicine shaped how doctors thought about this choice. The AFFIRM trial enrolled over 4,000 patients and found no survival advantage with rhythm control compared to rate control. In fact, mortality trended slightly higher in the rhythm-control group (23.8 percent at five years versus 21.3 percent), likely because antiarrhythmic drugs carry their own side effects and risks. Patients in the rhythm-control group were also hospitalized more often.
That said, this trial mostly enrolled older patients with well-tolerated persistent afib. For younger patients, those with significant symptoms, or people with heart failure, rhythm control (especially with catheter ablation rather than drugs alone) may offer real benefits. The right approach depends heavily on individual circumstances.
When Medications Don’t Work
For some people, medications fail to bring the heart rate down adequately or cause intolerable side effects. In these cases, a procedure called AV node ablation with pacemaker implantation becomes an option. This involves deliberately destroying the electrical connection between the upper and lower chambers of the heart, then implanting a pacemaker to drive the lower chambers at a normal rate. It’s essentially a permanent solution that guarantees rate control but commits you to a pacemaker for life.
Both American and European cardiology guidelines recommend this approach only after medications have been tried and failed, and after catheter ablation of the afib itself has either failed, isn’t feasible, or has been declined. It’s particularly considered for patients who have both permanent afib and heart failure with a weakened pump function.